Plasma Pharmacokinetic Characteristics of Risperidone and Their Relationship to Saliva Concentrations in Children with Psychiatric or Neurodevelopmental Disorders
- 1 July 2007
- journal article
- clinical trial
- Published by Elsevier BV in Clinical Therapeutics
- Vol. 29 (7), 1476-1486
- https://doi.org/10.1016/j.clinthera.2007.07.026
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Determination of risperidone and enantiomers of 9-hydroxyrisperidone in plasma by LC-MS/MSJournal of Chromatography B, 2007
- Risperidone Treatment of Children with Autistic Disorder: Effectiveness, Tolerability, and Pharmacokinetic ImplicationsJournal of Child and Adolescent Psychopharmacology, 2004
- Prevalence and Patterns of Use of Psychoactive Medicines in Individuals with Autism in the Autism Society of North CarolinaJournal of Child and Adolescent Psychopharmacology, 2002
- Trends in Antipsychotic Use in a Texas Medicaid Population of Children and Adolescents: 1996 to 2000Journal of Child and Adolescent Psychopharmacology, 2002
- Double-Blind, Placebo-Controlled Study of Risperidone for the Treatment of Disruptive Behaviors in Children With Subaverage IntelligenceAmerican Journal of Psychiatry, 2002
- Risperidone in Acutely Exacerbated SchizophreniaThe Journal of Clinical Psychiatry, 2000
- Risperidone-Carbamazepine InteractionsThe Journal of Clinical Psychiatry, 1998
- Ultrarapid metabolizers of debrisoquine: Characterization and PCR‐based detection of alleles with duplication of the CYP2D6 geneFEBS Letters, 1996
- Effects of Carbamazepine on Psychomotor Performance in Children as a Function of Drug Concentration, Seizure Type, and Time of MedicationEpilepsia, 1990
- Effect of Sodium Valproate on Psychomotor Performance in Children as a Function of Dose, Fluctuations in Concentration, and DiagnosisEpilepsia, 1987